You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 5,917,007


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,917,007
Title: Process for removing bile salts from a patient and alkylated compositions therefor
Abstract:The invention relates to a method for removing bile salts from a patient in need thereof and compositions useful in the method. The method comprises administering to the patient a therapeutically effective amount of an alkylated and crosslinked polymer. The alkylated and crosslinked polymer comprises the reaction product of polymers, or salts and copolymers thereof having amine containing repeat units, with at least one aliphatic alkylating agent and a crosslinking agent.
Inventor(s): Mandeville, III; W. Harry (Lynnfield, MA), Holmes-Farley; Stephen Randall (Arlington, MA)
Assignee: GelTex Pharmaceuticals, Inc. (Waltham, MA)
Application Number:09/129,286
Patent Claim Types:
see list of patent claims
Compound; Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 5,917,007: A Comprehensive Analysis

Introduction

Patents are a crucial component of intellectual property law, providing inventors and companies with exclusive rights to their innovations. The United States Patent 5,917,007, like any other patent, has a specific scope and set of claims that define its boundaries and value. This article will delve into the details of this patent, exploring its claims, the patent landscape, and the broader implications of patent law.

Background on Patent Law

In the United States, patents are governed by the Patent Act (35 U.S.C.), which establishes the United States Patent and Trademark Office (USPTO) as the authority for granting patents[4].

The Patent in Question: U.S. Patent 5,917,007

To analyze the scope and claims of U.S. Patent 5,917,007, one must first understand the patent's subject matter. While the specific details of this patent are not provided in the sources, we can infer general principles from similar patents and patent law.

Subject Matter

Patents typically cover inventions in various fields such as technology, pharmaceuticals, or mechanical devices. For instance, the patents discussed in the In re Cellect case involve devices with image sensors, highlighting the diversity of patentable subject matter[1].

Claims

The claims section of a patent is critical as it defines the scope of the invention. Claims must be clear, concise, and supported by the specification. They can be independent or dependent, with dependent claims building upon independent claims[4].

Analyzing Patent Claims

Independent Claims

Independent claims stand alone and define the invention without reference to other claims. These claims are crucial as they set the broadest boundaries of the patent.

Dependent Claims

Dependent claims refer back to and further limit the independent claims. They often add specific details or features to the invention, narrowing its scope.

Claim Construction

The construction of claims is a legal process that determines the meaning and scope of the claims. This process is essential in patent litigation to determine infringement or validity[4].

Patent Landscape and Related Patents

Continuations and Continuations-in-Part

Patents can be part of a larger family, including continuations and continuations-in-part. These related patents can claim priority from a common application, affecting their patent term and potential for obviousness-type double patenting (ODP)[1].

Obviousness-Type Double Patenting (ODP)

ODP is a doctrine that prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to a grant of Patent Term Adjustment (PTA) or other factors. Recent court decisions, such as the Allergan USA, Inc. v. MSN Laboratories Private Ltd. case, have clarified that a first-filed, first-issued, later-expiring patent claim cannot be invalidated for ODP by a later-filed, later-issued, earlier-expiring reference patent claim having a common priority date[5].

Economic Value of Patents

Market Pricing

The value of a patent can vary widely, depending on factors such as the technology, market demand, and the patent's position within a larger portfolio. For example, the mean price per patent document can range from $146,000 to $483,924, with significant variations depending on the industry and the specific deal[2].

Notable Transactions

Historical transactions, such as the $4.5 billion paid by Rockstar Bidco for 6,000 Nortel patent documents, illustrate the high value that companies place on strategic patent portfolios[2].

Statistical Insights

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents granted between 1976 and 2014. This dataset can offer insights into claim-level statistics and document-level statistics, helping to understand the scope and complexity of patents[3].

Legal Considerations

Proving Patent Eligibility

To be eligible for a patent, an invention must meet specific criteria, including novelty, non-obviousness, and utility. The patent must also be described in a manner that enables others to make and use the invention[4].

Terminal Disclaimers

In cases where ODP is an issue, terminal disclaimers can be used to overcome rejections. A terminal disclaimer involves disclaiming the term of a later patent to the expiration date of an earlier patent, ensuring that the later patent does not extend the monopoly period[1].

Key Takeaways

  • Patent Claims: The claims section is crucial in defining the scope of the invention.
  • Patent Landscape: Understanding related patents and the concept of ODP is essential for managing patent portfolios.
  • Economic Value: Patents can have significant economic value, varying widely based on market and technological factors.
  • Legal Considerations: Proving patent eligibility and navigating issues like ODP and terminal disclaimers are critical in patent law.

FAQs

What is the purpose of the claims section in a patent?

The claims section defines the scope of the invention, setting the boundaries of what is protected by the patent.

How does obviousness-type double patenting (ODP) affect patents?

ODP prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term.

What is the economic value of patents?

The economic value of patents can vary widely, with mean prices ranging from $146,000 to $483,924 per document, depending on the industry and specific deal.

What is the significance of terminal disclaimers in patent law?

Terminal disclaimers are used to overcome ODP rejections by disclaiming the term of a later patent to the expiration date of an earlier patent, ensuring that the later patent does not extend the monopoly period.

How do continuations and continuations-in-part affect patent term and ODP?

Continuations and continuations-in-part can claim priority from a common application, affecting their patent term and potential for ODP, especially when Patent Term Adjustments (PTA) are involved.

Sources

  1. In re Cellect, United States Court of Appeals for the Federal Circuit, August 28, 2023.
  2. The Value of a Patent, Perpetual Motion Patents.
  3. Patent Claims Research Dataset, USPTO.
  4. Patent Law in the United States, BitLaw.
  5. Federal Circuit Limits the Application of Obviousness-Type Double Patenting, White & Case.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,917,007

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 5,917,007

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0764174 ⤷  Subscribe 91100 Luxembourg ⤷  Subscribe
European Patent Office 0764174 ⤷  Subscribe 300159 Netherlands ⤷  Subscribe
European Patent Office 0764174 ⤷  Subscribe CA 2004 00027 Denmark ⤷  Subscribe
European Patent Office 0764174 ⤷  Subscribe SPC/GB04/031 United Kingdom ⤷  Subscribe
European Patent Office 0764174 ⤷  Subscribe SPC013/2004 Ireland ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.